Skip to main content
SpringerLink
Log in

Evaluation of IPPSE, an alternative method for sequential population PKPD analysis

  • Original Paper
  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

The aim of this study is to present and evaluate an alternative sequential method to perform population pharmacokinetic-pharmacodynamic (PKPD) analysis. Simultaneous PKPD analysis (SIM) is generally considered the reference method but may be computationally burdensome and time consuming. Evaluation of alternative approaches aims at speeding up the computation time and stabilizing the estimation of the models, while estimating the model parameters with good enough precision. The IPPSE method presented here uses the individual PK parameter estimates and their uncertainty (SE) to propagate the PK information to the PD estimation step, while the IPP method uses the individual PK parameters only and the PPP&D method utilizes the PK data. Data sets (n = 200) with various study designs were simulated according to a one-compartment PK model and a direct Emax PD model. The study design of each dataset was randomly selected. The same PK and PD models were fitted to the simulated observations using the SIM, IPP, PPP&D and IPPSE methods. The performances of the methods were compared with respect to estimation precision and bias, and computation time. Estimated precision and bias for the IPPSE method were similar to that of SIM and PPP&D, while IPP had higher bias and imprecision. Compared with the SIM method, IPPSE saved more computation time (61%) than PPP&D (39%), while IPP remained the fastest method (86% run time saved). The IPPSE method is a promising alternative for PKPD analysis, combining the advantages of the SIM (higher precision and lower bias of parameter estimates) and the IPP (shorter run time) methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Zhang L, Beal SL, Sheiner LB (2003) Simultaneous vs. sequential analysis for population PK/PD Data I: best case performance. J Pharmacokin Pharmacodyn 30:387–403

    Article  Google Scholar 

  2. Wade JR, Karlsson MO (1999) Combining PK and PD data during population PKPD analysis, p 8 Abstract 139 [www.page-meeting.org/?abstract=139]

  3. Savic RM, Karlsson MO (2009) Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J 11:558–569

    Article  PubMed  Google Scholar 

  4. Beal S, Sheiner LB, Boeckmann A, Bauer RJ (1989, 2009) NONMEM user’s guides, Icon Development Solutions, Ellicott City, MD, USA

  5. Sheiner L, Wakefield J (1999) Population modelling in drug development. Stat Methods Med Res 8:183–193

    Article  PubMed  CAS  Google Scholar 

  6. Beal S, Sheiner LB, Boeckmann A (1989, 2006) NONMEM user’s guides, Icon Development Solutions, Ellicott City, MD, USA

  7. Lindbom L, Pihlgren P, Jonsson EN (2005) PsN-Toolkit: a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 79:241–257

    Article  PubMed  Google Scholar 

  8. R Development Core Team (2008) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.R-project.org

  9. Gibaldi M, Perrier D (1982) Pharmacokinetics. Marcel Dekker, New York

    Google Scholar 

  10. Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL (2005) Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 55:601–607

    Article  PubMed  CAS  Google Scholar 

  11. Carnell R (2009) Latin hypercube samples package, http://cran.rproject.org/web/packages/lhs/index.html

  12. Ueckert S, Johansson ÅM, Plan EL, Hooker AC, Karlsson MO (2010) p 19 Abstract 1915 [www.page-meeting.org/?abstract=1915]

  13. Johansson ÅM, Ueckert S, Plan EL, Hooker AC, Karlsson MO (2010) p 19 Abstract 1922[www.page-meeting.org/?abstract=1922]

Download references

Author information

Authors and Affiliations

  1. Pharmacometrics Group, Dept of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden

    B. D. Lacroix, L. E. Friberg & M. O. Karlsson

  2. M&S Group, Dept of Global Exploratory Development, UCB Pharma, Braine-l’Alleud, Belgium

    B. D. Lacroix

Authors
  1. B. D. Lacroix
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. E. Friberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. O. Karlsson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. D. Lacroix.

Appendices

Appendix A

See Table 4

Table 4 Design and model parameters
Full size table

Appendix B

See Table 5

Table 5 Possible sampling times given the number of observation sampled for each subject (pkf and pdf)
Full size table

Appendix C - Extract NONMEM code for PD estimation using the IPPSE method

figure a

APPENDIX D - Extract NONMEM code for PD estimation using the PPP&D method

figure b

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lacroix, B.D., Friberg, L.E. & Karlsson, M.O. Evaluation of IPPSE, an alternative method for sequential population PKPD analysis. J Pharmacokinet Pharmacodyn 39, 177–193 (2012). https://doi.org/10.1007/s10928-012-9240-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10928-012-9240-x

Keywords

Search

Navigation